426 related articles for article (PubMed ID: 36510261)
1. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.
Liu C; Zhu J; Mi Y; Jin T
J Neuroinflammation; 2022 Dec; 19(1):298. PubMed ID: 36510261
[TBL] [Abstract][Full Text] [Related]
2. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
Kim SH; Jung HH; Lee CK
Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Flórez-Grau G; Zubizarreta I; Cabezón R; Villoslada P; Benitez-Ribas D
Front Immunol; 2018; 9():1169. PubMed ID: 29904379
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
Passeri L; Marta F; Bassi V; Gregori S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
[TBL] [Abstract][Full Text] [Related]
5. Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Gross CC; Jonuleit H; Wiendl H
Eur J Immunol; 2012 Mar; 42(3):569-72. PubMed ID: 22488360
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y
Front Immunol; 2021; 12():643240. PubMed ID: 33679806
[TBL] [Abstract][Full Text] [Related]
7. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
[TBL] [Abstract][Full Text] [Related]
8. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
Van Brussel I; Lee WP; Rombouts M; Nuyts AH; Heylen M; De Winter BY; Cools N; Schrijvers DM
Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737
[TBL] [Abstract][Full Text] [Related]
9. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
Wei HJ; Letterio JJ; Pareek TK
J Vis Exp; 2018 May; (135):. PubMed ID: 29863666
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells.
Jia S; Kim J; Esser-Kahn AP; Deak P
Front Med (Lausanne); 2023; 10():1298424. PubMed ID: 38249971
[TBL] [Abstract][Full Text] [Related]
11. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
12. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis.
Xie ZX; Zhang HL; Wu XJ; Zhu J; Ma DH; Jin T
Mediators Inflamm; 2015; 2015():513295. PubMed ID: 25705093
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
[TBL] [Abstract][Full Text] [Related]
14. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
[TBL] [Abstract][Full Text] [Related]
16. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.
Alipour S; Kazemi T; Sadeghi MR; Heris JA; Masoumi J; Naseri B; Baghbani E; Sohrabi S; Baradaran B
Int Immunopharmacol; 2024 Jan; 126():111230. PubMed ID: 37979448
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
Willekens B; Presas-Rodríguez S; Mansilla MJ; Derdelinckx J; Lee WP; Nijs G; De Laere M; Wens I; Cras P; Parizel P; Van Hecke W; Ribbens A; Billiet T; Adams G; Couttenye MM; Navarro-Barriuso J; Teniente-Serra A; Quirant-Sánchez B; Lopez-Diaz de Cerio A; Inogés S; Prosper F; Kip A; Verheij H; Gross CC; Wiendl H; Van Ham MS; Ten Brinke A; Barriocanal AM; Massuet-Vilamajó A; Hens N; Berneman Z; Martínez-Cáceres E; Cools N; Ramo-Tello C;
BMJ Open; 2019 Sep; 9(9):e030309. PubMed ID: 31501122
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis.
Link H; Huang YM; Masterman T; Xiao BG
J Neuroimmunol; 2001 Mar; 114(1-2):1-7. PubMed ID: 11240009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
